Description

1-(4-Chlorophenyl)-4-(Trifluoromethyl)[1,2,4]Triazolo[4,3-A]Quinoxaline is a high-purity, advanced heterocyclic compound that serves as a critical building block in modern chemical synthesis. Its unique fused triazoloquinoxaline core, functionalized with chlorophenyl and trifluoromethyl groups, makes it an invaluable intermediate for developing novel materials with specialized properties. This compound is primarily sought by research and development teams in the pharmaceutical and agrochemical sectors for the creation of new active ingredients and functional molecules.

Application

This specialized chemical intermediate enables innovation across several high-value industrial and research domains:

• Pharmaceutical Research & Development: A key scaffold for synthesizing novel drug candidates, particularly in therapeutic areas targeting the central nervous system, oncology, and infectious diseases.
• Agrochemical Innovation: Serves as a precursor in the development of next-generation pesticides, herbicides, and fungicides, leveraging its heterocyclic structure for bioactivity.
• Material Science: Used in the synthesis of advanced organic electronic materials, such as charge-transport layers or light-emitting components, due to its electron-deficient quinoxaline core.
• Chemical Biology & Proteomics: Employed as a molecular probe or tag in biochemical research to study protein interactions and enzyme functions.
• Organic Synthesis & Process Chemistry: A versatile building block for academic and industrial chemists exploring new reaction pathways and constructing complex molecular architectures.

Basic Information

Product Name	1-(4-Chlorophenyl)-4-(Trifluoromethyl)[1,2,4]Triazolo[4,3-A]Quinoxaline
CAS No.	338773-13-0
Molecular Formula	C₁₇H₉ClF₃N₄
Molecular Weight	361.73 g/mol
Synonyms	1-(4-Chlorophenyl)-4-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline; 4-(Trifluoromethyl)-1-(4-chlorophenyl)[1,2,4]triazolo[4,3-a]quinoxaline; [1,2,4]Triazolo[4,3-a]quinoxaline, 1-(4-chlorophenyl)-4-(trifluoromethyl)-; CTQ Derivative; Triazoloquinoxaline Intermediate; CAS 338773-13-0
EINECS	Contact for details

Quality Control

We maintain stringent quality control protocols for all our advanced intermediates. Production follows current Good Manufacturing Practice (cGMP) principles where applicable, and each batch is analyzed using validated methods including HPLC, NMR, and MS to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing purity, impurity profile, and physical characteristics is provided with every shipment to support your quality assurance and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. The container should be kept tightly sealed to protect this light-sensitive compound from degradation.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Unknown Impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.